2C-T-21
Template:Short description Template:Use mdy dates Template:Infobox drug
2C-T-21, also known as 4-(2-fluoroethylthio)-2,5-dimethoxyphenethylamine, is a psychedelic phenethylamine of the 2C family.<ref name="PiHKAL">Template:CitePiHKAL https://erowid.org/library/books_online/pihkal/pihkal049.shtml</ref> It is taken orally.<ref name="PiHKAL" />
2C-T-21 was first described in the scientific literature by Alexander Shulgin and colleagues in 1991.<ref name="ShulginShulginJacob1991" /> Shortly after this, Shulgin described 2C-T-17 in greater detail in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).<ref name="PiHKAL" />
Use and effects
In his book PiHKAL (Phenethylamines I Have Known And Loved), Alexander Shulgin lists the dose range as 8 to 12Template:Nbspmg orally and its duration as 7 to 10Template:Nbsphours.<ref name="PiHKAL" /> Its onset is described as 15Template:Nbspminutes to 1Template:Nbsphour and peak effects occur after 1 to 2Template:Nbsphours.<ref name="PiHKAL" /> The effects of 2C-T-21 have been described.<ref name="PiHKAL" />
Toxicity
On March 9, 2004, a 22-year-old quadriplegic man named James Edwards Downs in St. Francisville, Louisiana, consumed an unknown dose of 2C-T-21 by sticking his tongue into a vial of powder he had purchased online. He developed a temperature of Template:Convert,<ref name="urlNews from DEA, News Releases, 07/22/04">Template:Cite web</ref> had a tonic-clonic seizure, and slipped into a coma. Four days later, on March 13, Downs died at Lane Memorial Hospital in Zachary, LA.Template:Citation needed
This death became part of a two-year DEA investigation called Operation Web Tryp which was launched in 2002. On July 22, 2004, the owners of American Chemical Supply were arrested on federal charges relating to distribution of controlled substance analogues and the death of James Edwards Downs. Little is known about the toxicity of 2C-T-21 beyond this incident.
Interactions
Pharmacology
Pharmacodynamics
2C-T-21 shows high affinity for the serotonin 5-HT2A receptor (Ki = 27Template:NbspnM).<ref name="HalberstadtLuethiHoener2023">Template:Cite journal</ref> It produces the head-twitch response, a behavioral proxy of psychedelic-like effects, in rodents.<ref name="HalberstadtLuethiHoener2023" />
Chemistry
Synthesis
The chemical synthesis of 2C-T-21 has been described.<ref name="PiHKAL" />
Analogues
Analogues of 2C-T-21 include 2C-T-2, 2C-T-21.5, and 2C-T-22, among others.<ref name="HalberstadtLuethiHoener2023" /><ref name="PiHKAL" /><ref name="TrachselLehmannEnzensperger2013">Template:Cite book</ref>
History
2C-T-21 was first described in the scientific literature by Alexander Shulgin and colleagues in a journal article in 1991.<ref name="ShulginShulginJacob1991">Template:Cite journal</ref> Shortly thereafter, it was described in greater detail by Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).<ref name="PiHKAL" /> The potential applications of 2C-T-21 in psychedelic-assisted psychotherapy were explored by Myron Stolaroff.<ref name="Stolaroff1994">Template:Cite web</ref>
Society and culture
Legal status
2C-T-21 is unscheduled and uncontrolled in the United States, but possession and sales of 2C-T-21 would probably be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7 and its known potential to cause death. In the wake of Operation Web Tryp in July 2004, at least one distributor faced charges as a consequence of the death of James Downs from 2C-T-21 overdose.
Canada
As of October 31, 2016, 2C-T-21 is a controlled substance (Schedule III) in Canada.<ref>Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)</ref>
See also
References
External links
- 2C-T-21 - Isomer Design
- 2C-T-21 - PsychonautWiki
- 2C-T-21 - Erowid
- The Big & Dandy 2C-T-21 Thread - Bluelight
- 2C-T-21 - PiHKAL - Erowid
- 2C-T-21 - PiHKAL - Isomer Design
Template:Psychedelics Template:Serotonin receptor modulators Template:Phenethylamines